The UK Cosmetic, Toiletry and Perfumery Association (CTPA) has held its first scientific conference in London, a sold-out, member-only event convened under the theme 'Aligning Science, Policy and Consumer Perception'.

The one-day programme examined how scientific evidence, regulatory decision-making and public understanding intersect — a pressing question for dermatology-adjacent professionals as misinformation about cosmetic ingredients circulates widely online.

Speakers spanned the full stakeholder spectrum: UK government experts, international and European cosmetic and personal care associations, cosmetic companies, academics, journalists and communications consultants. The format mixed presentations with interactive workshops and panel discussions.

What did the programme cover?

The agenda addressed five scientific and regulatory topics relevant to anyone counselling patients on product safety:

• How consumers understand and respond to information about chemicals, including the distinction between hazard and risk;
• The latest developments in science-based policy and regulation shaping the cosmetics sector;
• Building confidence in animal-free safety assessment;
• Cutting-edge science behind UV filters and what the evidence shows about their impact on the marine environment;
• How effective science communication can build trust and confidence among consumers and the media.

The hazard-versus-risk session speaks directly to a recurring clinical problem: patients who avoid well-characterised ingredients based on hazard classifications alone, without dose and exposure context. The UV filter session took on another emotive topic — environmental impact claims that increasingly drive consumer choices away from photoprotection.

What did the CTPA say?

CTPA science director Caroline Rainsford framed the event as proof that cross-disciplinary work pays off.

"The event demonstrated the value of collaboration between scientists, regulators, policymakers and communications professionals in addressing important issues such as public understanding of science, trust in evidence, and the role of robust scientific data in informed decision-making," Rainsford said.

She also acknowledged the environment in which the conference took place. "At a time when misinformation can spread quickly, open discussion and clear communication are more important than ever. CTPA will continue to work on fostering collaboration across the scientific community to promote evidence-based approaches and support greater understanding of the science behind, and safety of, cosmetics and personal care products," she added.

Why does this matter for clinicians?

The conference's core premise — that robust data does not automatically translate into consumer trust — mirrors what clinicians face in consultations. Patients increasingly arrive with pre-formed beliefs about "chemical" ingredients, sunscreen safety and animal-testing claims formed outside the evidence base.

The animal-free safety assessment strand signals where regulatory science is heading. New Approach Methodologies are becoming the reference point for safety dossiers, and clinicians who field questions about product testing will encounter these frameworks more often.

For dermatology professionals, the CTPA's commitment to convening regulators, scientists and communicators under one roof suggests future editions could become a useful early indicator of policy direction for the UK cosmetics sector — particularly on UV filter regulation and environmental claims, both of which bear directly on photoproteption advice and patient adherence.